
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Income Statement | ||||||
Revenue | -- | $1.8B | $1.2B | $449M | -$114.6M | |
Gross Profit | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
Diluted EPS | -- | $0.39 | $0.38 | $0.09 | $0.11 |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | -- | -- | -- | $908M | $898.4M | |
Total Assets | -- | -- | -- | $18.3B | $19.6B | |
Current Liabilities | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | $16.5B | $17.8B | |
Total Equity | -- | -- | -- | $1.8B | $1.8B | |
Total Debt | -- | -- | -- | $269.9M | $649.5M |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | -- | $157.2M | -$96.3M | $111.9M | -$62.5M | |
Cash From Investing | -- | $15.3M | -$2.5M | -$325.9K | -$315.7K | |
Cash From Financing | -- | -$111.4M | $88.5M | -$325.9K | -$736.6K | |
Free Cash Flow | -- | $151.2M | -$98.8M | $111.6M | -$62.8M |
Mandatum PLC is a financial services provider that combines expertise in wealth management and life insurance. It offers clients a wide array of services covering asset and wealth management, savings and investment, compensation and rewards as well as pension plans and personal risk insurance. The reportable segments are: Institutional & wealth management, Corporate clients, Retail clients and With-profit business.
In the current month, MANDF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MANDF average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Mandatum PLC share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Mandatum PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Mandatum PLC is a Sell and believe this share price will rise from its current level to --.
The price target for Mandatum PLC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Mandatum PLC is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Mandatum PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Mandatum PLC shares.
Mandatum PLC was last trading at $6.38 per share. This represents the most recent stock quote for Mandatum PLC. Yesterday, Mandatum PLC closed at $6.38 per share.
In order to purchase Mandatum PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.